Literature DB >> 8649404

Regulation of telomerase activity in immortal cell lines.

S E Holt1, W E Wright, J W Shay.   

Abstract

Telomerase is a ribonucleoprotein whose activity has been detected in germ line cells, immortal cells, and most cancer cells. Except in stem cells, which have a low level of telomerase activity, its activity is absent from normal somatic tissues. Understanding the regulation of telomerase activity is critical for the development of potential tools for the diagnosis and treatment of cancer. Using the telomeric repeat amplification protocol, we found that immortal, telomerase-positive, pseudodiploid human cells (HT1080 and HL60 cells) sorted by flow repressed in quiescent cells. This was true whether quiescence was induced by contact inhibition (NIH 3T3 mouse cells), growth factor removal (bromodeoxyuridine-blocked mouse myoblasts), reexpression of cellular senescence (the reversibly immortalized IDH4 cells), or irreversible cell differentiation (HL60 promyelocytic leukemia cells and C2C12 mouse myoblasts). Taken together, these results indicate that telomerase is active throughout the cell in dividing, immortal cells but that its activity is repressed in cells that exit the cell cycle. This suggests that quiescent stem cells that have the potential to express telomerase may remain unaffected by potential antitelomerase cancer therapies.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8649404      PMCID: PMC231287          DOI: 10.1128/MCB.16.6.2932

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  34 in total

1.  Telomere positional effects and the regulation of cellular senescence.

Authors:  W E Wright; J W Shay
Journal:  Trends Genet       Date:  1992-06       Impact factor: 11.639

2.  A mutant with a defect in telomere elongation leads to senescence in yeast.

Authors:  V Lundblad; J W Szostak
Journal:  Cell       Date:  1989-05-19       Impact factor: 41.582

3.  A telomeric sequence in the RNA of Tetrahymena telomerase required for telomere repeat synthesis.

Authors:  C W Greider; E H Blackburn
Journal:  Nature       Date:  1989-01-26       Impact factor: 49.962

4.  Increased resistance to apoptosis associated with HL-60 myeloid differentiation status.

Authors:  J V McCarthy; R S Fernandes; T G Gotter
Journal:  Anticancer Res       Date:  1994 Sep-Oct       Impact factor: 2.480

5.  Telomeres shorten during ageing of human fibroblasts.

Authors:  C B Harley; A B Futcher; C W Greider
Journal:  Nature       Date:  1990-05-31       Impact factor: 49.962

6.  Role of gelsolin in the formation and organization of triton-soluble F-actin during myeloid differentiation of HL-60 cells.

Authors:  R G Watts
Journal:  Blood       Date:  1995-04-15       Impact factor: 22.113

7.  Specific association of human telomerase activity with immortal cells and cancer.

Authors:  N W Kim; M A Piatyszek; K R Prowse; C B Harley; M D West; P L Ho; G M Coviello; W E Wright; S L Weinrich; J W Shay
Journal:  Science       Date:  1994-12-23       Impact factor: 47.728

8.  The BrdU content of DNA is decreased during reversal of inhibition of myogenesis by deoxycytidine.

Authors:  W E Wright
Journal:  Somatic Cell Genet       Date:  1982-09

9.  Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity.

Authors:  C M Counter; A A Avilion; C E LeFeuvre; N G Stewart; C W Greider; C B Harley; S Bacchetti
Journal:  EMBO J       Date:  1992-05       Impact factor: 11.598

10.  Human telomeres are attached to the nuclear matrix.

Authors:  T de Lange
Journal:  EMBO J       Date:  1992-02       Impact factor: 11.598

View more
  78 in total

1.  Establishment of novel human esophageal cancer cell line in relation to telomere dynamics and telomerase activity.

Authors:  Y Kiyozuka; A Asai; D Yamamoto; H Senzaki; S Yoshioka; H Takahashi; K Hioki; A Tsubura
Journal:  Dig Dis Sci       Date:  2000-05       Impact factor: 3.199

2.  Functional requirement of p23 and Hsp90 in telomerase complexes.

Authors:  S E Holt; D L Aisner; J Baur; V M Tesmer; M Dy; M Ouellette; J B Trager; G B Morin; D O Toft; J W Shay; W E Wright; M A White
Journal:  Genes Dev       Date:  1999-04-01       Impact factor: 11.361

Review 3.  Complex regulation of telomerase activity: implications for cancer therapy.

Authors:  K S Elenitoba-Johnson
Journal:  Am J Pathol       Date:  2001-08       Impact factor: 4.307

4.  E2F-1 represses transcription of the human telomerase reverse transcriptase gene.

Authors:  D L Crowe; D C Nguyen; K J Tsang; S Kyo
Journal:  Nucleic Acids Res       Date:  2001-07-01       Impact factor: 16.971

5.  An ES-like cell line from the marine fish Sparus aurata: characterization and chimaera production.

Authors:  Julia Béjar; Yunhan Hong; M Carmen Alvarez
Journal:  Transgenic Res       Date:  2002-06       Impact factor: 2.788

6.  Putative telomere-recruiting domain in the catalytic subunit of human telomerase.

Authors:  Blaine N Armbruster; Katherine T Etheridge; Dominique Broccoli; Christopher M Counter
Journal:  Mol Cell Biol       Date:  2003-05       Impact factor: 4.272

7.  RNAi screen for telomerase reverse transcriptase transcriptional regulators identifies HIF1alpha as critical for telomerase function in murine embryonic stem cells.

Authors:  Matthew Coussens; Philip Davy; Lancer Brown; Christopher Foster; William H Andrews; Melissa Nagata; Richard Allsopp
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-19       Impact factor: 11.205

Review 8.  The role of telomeres and telomerase reverse transcriptase isoforms in pluripotency induction and maintenance.

Authors:  Jonathan H Teichroeb; Joohwan Kim; Dean H Betts
Journal:  RNA Biol       Date:  2016-01-19       Impact factor: 4.652

9.  Effects of allicin on both telomerase activity and apoptosis in gastric cancer SGC-7901 cells.

Authors:  Li Sun; Xu Wang
Journal:  World J Gastroenterol       Date:  2003-09       Impact factor: 5.742

10.  N-terminal domains of the human telomerase catalytic subunit required for enzyme activity in vivo.

Authors:  B N Armbruster; S S Banik; C Guo; A C Smith; C M Counter
Journal:  Mol Cell Biol       Date:  2001-11       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.